Literature DB >> 12351554

Endometriosis results from the dislocation of basal endometrium.

G Leyendecker1, M Herbertz, G Kunz, G Mall.   

Abstract

BACKGROUND: The hypothesis is tested that both adenomyotic and endometriotic lesions are derived from basal endometrium.
METHODS: Normal uteri and uteri with adenomyosis obtained by hysterectomy, excised endometriotic lesions and menstrual blood of women with and without endometriosis were used. Estrogen receptor (ER), progesterone receptor (PR), progesterone receptor B isoform (PR(B)) and P450 aromatase (P450A) immunohistochemistry was performed with the use of specific monoclonal antibodies.
RESULTS: With respect to the parameters studied there was a fundamental difference between the cyclical patterns of the basalis and the functionalis of the eutopic endometrium. The endometrium of endometriotic and adenomyotic lesions mimicked the cyclical pattern of the basalis. The peristromal muscular tissue of endometriotic and adenomyotic lesions displayed the same cyclical pattern of ER and PR expression as the archimyometrium. There was a significantly higher prevalence of fragments of shed basalis in menstrual blood of women with endometriosis than in healthy controls.
CONCLUSIONS: These data suggest that ectopic endometrial lesions result from dislocation of basal endometrium. Dislocated basal endometrium has stem cell character resulting in the ectopic formation of all archimetrial components such as epithelial and stromal endometrium as well as peristromal muscular tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351554     DOI: 10.1093/humrep/17.10.2725

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  40 in total

1.  The diagnosis and treatment of deep infiltrating endometriosis.

Authors:  Gülden Halis; Sylvia Mechsner; Andreas D Ebert
Journal:  Dtsch Arztebl Int       Date:  2010-06-25       Impact factor: 5.594

Review 2.  The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis.

Authors:  Demetra Hufnagel; Fei Li; Emine Cosar; Graciela Krikun; Hugh S Taylor
Journal:  Semin Reprod Med       Date:  2015-09-16       Impact factor: 1.303

Review 3.  Stem cell and endometriosis: new knowledge may be producing novel therapies.

Authors:  Jing Yang; Fengying Huang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Co-culture with macrophages enhances the clonogenic and invasion activity of endometriotic stromal cells.

Authors:  Rachel W S Chan; Cheuk-Lun Lee; Ernest H Y Ng; William S B Yeung
Journal:  Cell Prolif       Date:  2017-01-10       Impact factor: 6.831

5.  Endometriosis research using capture microdissection techniques: Progress and future applications.

Authors:  Luyang Zhao; Chenglei Gu; Ke Huang; Weidong Han; Meng Fu; Yuanguang Meng
Journal:  Biomed Rep       Date:  2016-09-15

6.  Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis.

Authors:  Rachel Wah Shan Chan; Ernest Hung Yu Ng; William Shu Biu Yeung
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

7.  Use of a murine endometriosis interna model for the characterization of compounds that effectively treat human endometriosis.

Authors:  Christiane Otto; Jenny Schkoldow; Elisabeth Krahl; Iris Fuchs; Hannes-Friedrich Ulbrich
Journal:  Exp Ther Med       Date:  2011-12-20       Impact factor: 2.447

Review 8.  Stem cells and the pathogenesis of endometriosis.

Authors:  Isaac E Sasson; Hugh S Taylor
Journal:  Ann N Y Acad Sci       Date:  2008-04       Impact factor: 5.691

Review 9.  Pathophysiology and Immune Dysfunction in Endometriosis.

Authors:  Soo Hyun Ahn; Stephany P Monsanto; Caragh Miller; Sukhbir S Singh; Richard Thomas; Chandrakant Tayade
Journal:  Biomed Res Int       Date:  2015-07-12       Impact factor: 3.411

10.  The pathophysiology of endometriosis and adenomyosis: tissue injury and repair.

Authors:  G Leyendecker; L Wildt; G Mall
Journal:  Arch Gynecol Obstet       Date:  2009-07-31       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.